Kangstem Biotech Co., Ltd. Stock: price and insider trades · South Korea
강스템바이오텍
No insider purchase over the last 90 days. The latest, by 강경선, was filed 03 Apr 2026.
Kangstem Biotech Co., Ltd.: what insiders have been doing
Kangstem Biotech Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through DART (FSS). From 1 November 2025 to 1 November 2026, the disclosure feed for Kangstem Biotech Co., Ltd. logged 9 filings by 9 insiders.
Not one open-market sale was filed. On the buying side, 8 insiders reported 8 purchases. No amount is published for 8 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 4 senior executives, 2 board members and 1 chief executive.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 9 filings, this issuer sits above that mark. Since 2021, the database holds 32 purchases and 4 sales by insiders of the company.
The last insider purchase was made public on 3 April 2026, 219 days ago.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySale+5 other insiders
Since the insiders bought
- -41.9%Entry ₩3,220 · Close 30 Oct 2026 ₩1,872
- -23.1%Entry ₩1,560 · Close at T+365 ₩1,199
- -23.1%Entry ₩1,560 · Close at T+365 ₩1,199
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 947,000 sharesKRXDART:20260403000828Canonical exit: 28 Jun 2026 (T+90)
- ●Executives0DART
- 2,000 sharesShareKRXDART:20260203000327Canonical exit: 4 May 2026 (T+90)
- 4,000 sharesShareKRXDART:20260203000321Canonical exit: 4 May 2026 (T+90)
- 1,300 sharesShareKRXDART:20260203000348Canonical exit: 4 May 2026 (T+90)
- 10,637 sharesShareKRXDART:20260203000331Canonical exit: 4 May 2026 (T+90)
- 20,000 sharesShareKRXDART:20260203000304Canonical exit: 4 May 2026 (T+90)
- 1,500 sharesShareKRXDART:20260203000344Canonical exit: 4 May 2026 (T+90)
- 10,000 sharesShareKRXDART:20260203000340Canonical exit: 4 May 2026 (T+90)
- 10,179 sharesKRXDART:20250901000346Canonical exit: 24 Nov 2025 (T+90)
- 2,406 sharesShareKRXDART:20250828000466Canonical exit: 26 Nov 2025 (T+90)
- Other0DART
- 616 sharesShareKRXDART:20250828000471Canonical exit: 26 Nov 2025 (T+90)
- 625 sharesShareKRXDART:20250828000443Canonical exit: 26 Nov 2025 (T+90)
- 11,149 sharesShareKRXDART:20250828000442Canonical exit: 26 Nov 2025 (T+90)
- 3,641 sharesShareKRXDART:20250828000460Canonical exit: 26 Nov 2025 (T+90)
- 148 sharesShareKRXDART:20250828000495Canonical exit: 26 Nov 2025 (T+90)
- Other0DART
- 4,068 sharesShareKRXDART:20250828000475
- 6,108 sharesShareKRXDART:20250828000447
- 1,362,224 sharesKRXDART:20250826000440Canonical exit: 24 Nov 2025 (T+90)
- 1,362,224 sharesShareKRXDART:20250826000454Canonical exit: 24 Nov 2025 (T+90)
- 826,935 sharesKRXDART:20250806000194Canonical exit: 28 Oct 2025 (T+90)
- 9,254,149 sharesKRXDART:20250806000322Canonical exit: 28 Oct 2025 (T+90)
- 66,192 sharesShareKRXDART:20250806000213
25 of 132 declarations
About Kangstem Biotech Co., Ltd.
강스템바이오텍 is a biotechnology company focused on developing cell and gene therapies. It is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
